CRISM Therapeutics Provides Shareholder Update
Why we think this is neutral
This RNS announcement from CRISM Therapeutics does not contain any of the mandatory news types specified, such as contract news, order news, trading update, financing, or annual results. The announcement simply provides an update on the company's shareholder register, which is informational in nature and does not indicate any significant positive or negative developments.
Key Points
- CRISM Therapeutics provides update on shareholder register
- Top shareholders include Andrew Webb, Christopher McConville, Brian Murray, and David Lawton
- Linista Group Inc. and Spreadex no longer hold disclosable shareholdings
Summary
CRISM Therapeutics Corporation has announced the results of an independent third-party shareholder register analysis as at 31 December 2025. The analysis reveals the company's top shareholders, including Andrew Webb, Christopher McConville, Brian Murray, and David Lawton. The announcement also notes that neither Linista Group Inc. nor Spreadex hold a disclosable shareholding in the company following recent share issuances.